(A) A nursing home or community residential care facility as defined in Section 44-7-130 shall: (1) prior to the admission of a new resident, request and receive a written declaration from an authorized health care provider that, based upon medical examination of the applicant resident, the applicant resident has no signs or symptoms of active tuberculosis;(2) within three days of a resident's admission to the nursing home or community residential care facility from a hospital, as defined in Section 44-7-130, administer the first step of the two-step tuberculin skin test to the resident; and(3) within fourteen days of that resident's admission, administer the second step of the tuberculin skin test to the resident.(B)(1) The nursing home or community residential care facility may substitute a single blood assay for mycobacterium tuberculosis for a two-step tuberculin skin test; or(2) administer a single tuberculin skin test or single blood assay for mycobacterium tuberculosis within fourteen days of the resident's admission from a hospital if the nursing home or community residential care facility has documentation that within the twelve-month period prior to admission, the resident obtained a negative tuberculin skin test or a negative single blood assay for mycobacterium tuberculosis.Added by 2024 S.C. Acts, Act No. 162 (SB 558),s 1, eff. 5/20/2024.